Drug abuse and bipolar disorder: Comorbidity or misdiagnosis?

Journal of Affective Disorders

Volumn 65, Issue 2, 2001, Pages 105-115

  Sherwood Brown, E ^a   Suppes, Trisha ^a   Adinoff, Bryon ^a,b   Rajan Thomas, Nancy ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Bipolar disorder; Mood stabilizers; Neuroleptics; Substance abuse

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

AFFECTIVE NEUROSIS; ALCOHOLISM; CANNABIS ADDICTION; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; DIAGNOSTIC ERROR; DRUG DEPENDENCE; DYSPHORIA; DYSTHYMIA; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; OPIATE ADDICTION; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SYMPTOM;

BIPOLAR DISORDER; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC ERRORS; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 0035036968     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00169-5     Document Type: Review

References (100)

1. Aagaard J., Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J. Affect. Disord. 12:1989;259-266.
2. Akiskal H.S., Djenderedijian A.H., Rosenthal R.H., Khani M.K. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am. J. Psychiatry. 134:1977;1227-1233.
3. Akiskal H.S., Downs J., Jordan P., Watson S., Daugherty D., Pruitt D.B. Affective disorders in referred children and younger siblings of manic-depressives: mode of onset and prospective course. Arch. Gen. Psychiatry. 42:1985;996-1003.
4. Albanase M.J., Khantzian E.J., Murphy S.L. Decreased substance use in chronically psychotic patients treated with clozapine. Am. J. Psychiatry. 151:1994;780-781. Letter.
5. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch. Gen. Psychiatry. 42:1985;1193-1204.
6. Bauer M.S., Shea N., McBride L., Gavin C. Predictors of service utilization in veterans with bipolar disorder: a prospective study. J. Affect. Disord. 44:1997;159-168.
7. Baumann M.H., Gendro T.M., Becketts K.M., Heningfield J.E., Gorelick D.A., Rothman R.B. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol. Psychiatry. 38:1995;751-755.
8. Brady K., Casto S., Lydiard R.B., Lalcolm R., Arana G. Substance abuse in an inpatient psychiatric sample. Am. J. Drug Alcohol Abuse. 17:1991;389-397.
9. Brady K.T., Sonne S.C. The relationship between substance abuse and bipolar disorder. J. Clin. Psychiatry. 56:1995;19-24.
10. Brady K.T., Sonne S.C., Anton R., Ballenger J.C. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J. Clin. Psychiatry. 56:1995;118-121.
11. Brady K.T., Sonne S.C., Dansky B.S., Roberts J.C., Malcolm R.J. Carbamazepine in cocaine-dependent individuals with affective disorder. College on Problems of Drug Dependence Annual Meeting, Scottsdale, AZ. 1998.
12. Bradley C.J., Zarkin G.A. Inpatient stays for patients diagnosed with severe psychiatric disorders and substance abuse. Health Serv. Res. 31:1996;339-408.
13. Britton D.R., Curzon P., Mackenzie R.G., Kebabian J.W., Williams J.E.B., Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39:1991;911-915.
14. Brooner R.K., King V.L., Kidord M., Schmidt C.W. Jr., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry. 54:1997;71-80.
15. Brown S.A., Inaba R.K., Gillin J.C., Schuckit M.A., Stewart B.A., Irwin M.R. Alcoholism and affective disorder: clinical course of depressive symptoms. Am. J. Psychiatry. 152:1995;45-52.
16. Buckley P.F. Substance abuse in schizophrenia: a review. J. Clin. Psychiatry. 59:1998;26-30.
17. Chen Y.R., Swann A.C., Johnson B.A. Stability of diagnosis in bipolar disorder. J. Nerv. Ment. Dis. 186:1998;17-23.
18. Corrigall W.A., Coen K.M. Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol. Biochem. Behav. 39:1991;799-802.
19. de la Garza R., Johanson C.E. Effects of haloperidol and physostigmine on self-administration of local anesthetics. Pharmacol. Biochem. Behav. 17:1982;1295-1299.
20. D'Mello D.A., Boltz M.K., Msibi B. Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. Am. J. Drug Alcohol Abuse. 21:1995;257-265.
21. Dell'Osso L., Akiskal H.S., Freer P., Barberi M., Placidi G.F., Cassano G.B. Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 243:1993;75-81.
22. Deroche V., Marinelli M., Maccari S., Moal M.L., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7181-7188.
23. Dunner D.L., Hensel B.M., Fieve R.R. Bipolar illness: factors in drinking behavior. Am. J. Psychiatry. 136:1979;583-585.
24. Estroff T.W., Dackis C.A., Gold M.S., Pottash A.L.C. Drug abuse and bipolar disorders. Int. J. Psychiatry Med. 15:1985;37-40.
25. Ettenberg A., Pettit H.O., Bloom F.E., Koob G.F. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacol. (Berl.). 78:1982;204-209.
26. Feinman J.A., Dunner D.L. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J. Affect. Disord. 37:1996;43-49.
27. Forman L.J., Estilow S. Cocaine influences beta-endorphin levels and release. Life Sci. 43:1988;309-315.
28. Freed E.X. Alcohol abuse by manic patients. Psychol. Rep. 25:1969;280.
29. Gawin F.H., Kleber H.D. Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Arch. Gen. Psychiatry. 41:1984;903-909.
30. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry. 43:1986;107-113.
31. Geller B., Cooper T.B., Sun K., Zimerman B., Frazier J., Williams M., Health J. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J. Am. Acad. Child Adolesc. Psychiatry. 37:1998;171-178.
32. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology. 22:1997;237-259.
33. Goeders N.E., Guerin G.F. Role for corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 64:1996;337-348.
34. Goodwin F.K., Jamison K.R. Alcohol and drug abuse in manic-depressive illness. Manic-Depressive Illness. 1990;210-226 Oxford. Chapter 9.
35. Haywood T.W., Karvitz H.M., Grossman L.S., Cavanaugh J.L. Jr., Davis J.M., Lewis D.A. Predicting the 'Revolving Door' phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am. J. Psychiatry. 152:1995;856-861.
36. Heesch C.M., Negus B.H., Keffer J.H., Snyder R.W., Risser R.C., Eichorn E.J. Effects of cocaine on cortisol secretion in humans. Am. J. Med. Sci. 320:1995;61-64.
37. Himmelhoch J.M., Garfinkel M. Sources of lithium resistance in mixed mania. Psychopharmacol. Bull. 22:1986;613-620.
38. Himmelhoch J.M., Mulla D., Neil J.F., Detre T.P., Kupfer J.D. Incidence and significance of mixed affective states in a bipolar population. Arch. Gen. Psychiatry. 33:1976;1062-1066.
39. Johanson C.E., Kandel D., Bonese K.F. The effects of perphenazine on self-administration behavior. Pharmacol. Biochem. Behav. 4:1976;427-433.
40. Keck P.E., McElroy S.L., Strakowski S.M., Balistreri T.M., Kizer D.J., West S.A. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J. Clin. Psychol. 57:1996;147-151.
41. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am. J. Orthopsychiatry. 66:1996;17-31.
42. Koob G.F., Le H.T., Creese I. D-1 receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-321.
43. Kosten T.R., Nestler E.J. Clozapine attenuates cocaine conditioned place preference. Life Sci. 55:1994;PL9-14.
44. Krauthammer C., Klerman G.L. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch. Gen. Psychiatry. 35:1978;1333-1339.
45. Lambert M.T., Griffith J.M., Hendrickse W. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA medical center. Psychiatr. Serv. 47:1996;1104-1107.
46. LeDuc P.A., Mittleman G. Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology. 12:1995;407-427.
47. Levy A.D., Li Q., Kerr J.E., Rittenhouse P.A., Milonas G., Cabrera T.M., Battaglia G., Alvarez Sanz M.C., Van deKar L.D. Cocaine-induced elevation of plasma adrenocorticotropic hormone and corticosterone is medicated by serotonergic neurons. J. Pharmacol. Exp. Ther. 259:1991;495-500.
48. Marcus P., Snyder R. Reduction of comorbid substance abuse with clozapine. Am. J. Psychiatry. 152:1995;959. Letter.
49. Marken P.A., Stanislav S.W., Lacombe S., Pierce C., Horstra R., Sommi R.W. Profile of a sample of subjects admitted to an acute care psychiatric facility with manic symptoms. Psychopharmacol. Bull. 28:1992;201-205.
50. Martin-Iverson M.T., Szostak C., Fibiger H.C. 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacol. (Berl.). 88:1986;310-324.
51. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.L., Faedda G.L., Swann A.C., Stokes P.E., Casper R., Secunda S.K., Bowden C.L., Berman N., Katz M.M., Robins E. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr. Scand. 85:1992;270-274.
52. McElroy S.L., Strakowski S.M., West S.A., Keck P.E. Jr., McConville B.J. Phenomenology of adolescent and adult mania in hospitalized patients with bipolar disorder. Am. J. Psychiatry. 1541:1997;44-49.
53. Mendelson J.H., Mello N.K., Teoh S.K., Ellingboe J., Cochin J. Cocaine effects on pulsatile secretion of anterior pituitary gonadal, and adrenal hormones. J. Clin. Endocrinol. Metab. 69:1989;1256-1260.
54. Mendelson J.H., Teoh S.K., Mello N.K., Ellingboe J. Bupronorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. Neuropsychopharmacology. 7:1992;157-162.
55. Mendlewicz J., Fieve R.R., Rainer J.D., Fleiss J.L. Manic-depressive illness: a comparative study of patients with and without a family history. Am. J. Psychiatr. 120:1972;523-530.
56. Miller F.T., Busch F., Tanenbaum J.H. Drug abuse in schizophrenia and bipolar disorder. Am. J. Drug Alcohol Abuse. 15:1989;291-295.
57. Moldow R.L., Fischman A.J. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides. 8:1987;819-822.
58. Morrison J.R. Bipolar affective and alcoholism. Am. J. Psychiatry. 131:1974;1130-1133.
59. Mueser K.T., Yarnold P.R., Bellack A.S. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr. Scand. 85:1992;48-55.
60. Nunes E.V., Quitkin F.M., Klein D.F. Psychiatric diagnosis in cocaine abuse. Psychiatr. Res. 28:1989;105-114.
61. Nunes E.V., McGrath P.J., Wager S., Quitkin F.M. Lithium treatment for cocaine abusers with bipolar spectrum disorders. Am. J. Psychiatry. 147:1990;655-657.
62. O'Connell R., Mayo J., Flatow L., Cuthbertson B., O'Brien B. Outcome of bipolar disorder on long-term treatment with lithium. Br. J. Psychiatry. 159:1991;123-129.
63. O'Croinin F., Zibin T., Byrne A. Life events and relapse in bipolar disorder. Br. J. Psychiatry. 164:1994;417. Letter.
64. Peet M., Peters S. Drug-induced mania. Drug Safety. 12:1995;146-153.
65. Piazza P.V., Maccari S., Deminière J.M., LeMoal M., Mormède P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA. 88:1991;2088-2092.
66. Piazza P.V., Deroche V., Deminière J.M., Maccari S., LeMoal M., Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc. Natl. Acad. Sci. USA. 90:1993;11738-11742.
67. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. J. Am. Med. Assoc. 264:1990;2511-2518.
68. Risner M.E., Jones B.E. Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacol. Biochem. Behav. 5:1976;477-482.
69. Roberts D.C.S., Vickers G. Atypical neuroleptics increase self-administration of cocaine: an valuation of a behavioral screen for antipsychotic activity. Psychopharmacol. (Berl.). 82:1984;135-139.
70. Roberts D.C.S., Vickers G. The effect of haloperidol on cocaine self-administration is augmented with repeated administrations. Psychopharmacology. 293:1987;526-528.
71. Rounsaville B.J., Anton S.F., Carroll K., Budde D., Prusoff B.A., Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch. Gen. Psychiatry. 48:1991;43-51.
72. Saphier D., Welch J.E., Farrar G.E., Goeders N.E. Effects of intracerebro-ventricular and intrahypothalamic cocaine administration on adrenocortical secretion. Neuroendocrinology. 57:1993;54-62.
73. Satija D.C., Sharma D.K., Gaur A., Nathawat S.S. Prognostic significance of psychopathology in the abstinence from opiate addiction. Indian J. Psychiatr. 31:1989;157-162.
74. Saxon A.J., Calsyn D.A., Stanton V., Hawker C.S. Using the general behavior inventory to screen for mood disorders among patients with psychoactive substance dependence. Am. J. Addict. 3:1994;296-305.
75. Schatzberg A.F. Bipolar disorder: recent issues in diagnosis and classification. J. Clin. Psychiatry. 59:1998;5-10.
76. Schuckit M.A. Alcohol and depression: a clinical perspective. Acta Psychiatr. Scand. 89:1994;28-32.
77. Schuckit M.A., Tipp J.E., Bergman M., Reich W. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am. J. Psychiatry. 154:1997;948-957.
78. Scott H., Johnson S., Menezes P., Thornicroft G., Marshall J., Bindman J., Bebbington P., Kupiers E. Substance misuse and risk of aggression and offending among the severely mentally ill. Br. J. Psychiatry. 172:1998;345-350.
79. Sernyak M.J., Godleski L.S., Griffin R.A., Mazure C.M., Woods S.C. Chronic neuroleptic exposure in bipolar outpatients. J. Clin. Psychiatry. 58:1997;193-195.
80. Sonne S.C., Brady K.T., Morton W.A. Substance abuse and bipolar affective disorder. J. Nerv. Ment. Dis. 182:1994;349-352.
81. Strakowski S.M., Tohen M., Stoll A.L., Faedda G.L., Goodwin D.C. Comorbidity in mania at first hospitalization. Am. J. Psychiatry. 149:1992;554-556.
82. Strakowski S.M., McElroy S.L., Keck P.E. Jr., West S.A. The effects of antecedent substance abuse on the development of first-episode psychotic mania. J. Psychiatr. Res. 30:1996;59-68.
83. Suppes T., Leverich G.S., Keck P.E. Jr., Nolen W.A., Denicoff K.D., Altshuler L.L., Melroy S.L., Rush A.J., Kupka R., Frye M.A., Bickel M., Post R.M. The Stanley Foundation Bipolar Treatment Outcome Network: II. Demographics and illness characteristics of the first 261 patients. J. Affect. Disord. 2000;. in press.
84. Swann A.C. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am. J. Psychiatry. 149:1992;1633-1644.
85. Swann A.C. Manic-depressive illness and substance abuse. Psychiatr. Ann. 27:1997;507-511.
86. Todd R.D., Geller B., Neuman R., Fox L.W., Kickok J. Increased prevalence of alcoholism in relatives of depressed and bipolar children. J. Am. Acad. Child Adolesc. Psychiatry. 35:1996;716-724.
87. Tohen M., Waternaux C., Tsuang M. Outcome in mania, a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch. Gen. Psychiatry. 47:1990;1106-1111.
88. Tsuang J.W., Eckman T.E., Shaner A., Marder S.R. Clozapine for substance-abusing schizophrenic patients. Am. J. Psychiatry. 156:1999;1119-1120. Letter.
89. Vanover K.E., Piercey M.F., Woolverton W.L. Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)AJ76 or clozapine. J. Pharmacol. Exp. Ther. 266:1993;789.
90. Vollenweider F.X., Maguire R.P., Leenders K.L., Mathys K., Angst J. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res. 83:1998;149-162.
91. Warner R., Taylor D., Wright J., Sloat A., Springett G., Arnold S., Weinberg H. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am. J. Orthopsychiatry. 64:1994;30-39.
92. Weiss R.D., Mirin S.M., Griffin M.L., Michael J.L. Psychopathology in cocaine abusers. J. Nerv. Ment. Dis. 176:1988;719-725.
93. Weiss R.D., Greenfield S.F., Najavits L.M., Soto J.A., Wyner D., Tohen M., Griffin M.L. Medication compliance among patients with bipolar disorder and substance use disorder. J. Clin. Psychiatry. 59:1998;172-174.
94. Wilens T.E., Biederman J., Abrantes A.M., Spencer T.J. Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. J. Am. Acad. Child Adolesc. Psychiatry. 36:1997;941-947.
95. Wilson M.C., Schuster C.R. The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia. 26:1972;115-126.
96. Winokur G., Coryell W., Endicott J., Keller M., Akiskal H., Solomon D. Familial alcoholism in manic-depressive (bipolar) disease. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 67:1996;197-201.
97. Winokur G., Turvey C., Akiskal H., Coryell W., Solomon D., Leon A., Mueller T., Endicott J., Maser J., Keller M. Alcoholism and drug abuse in three groups - bipolar I, unipolars and their acquaintances. J. Affect. Disord. 50:1998;81-89.
98. 2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24:1986;531-535.
99. Yokel R.A., Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: implication for a dopamine theory of reward. Science. 187:1975;547-549.
100. Yovell Y., Opler L.A. Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis. J. Nerv. Ment. Dis. 182:1994;591-592.